CIK 0001540171 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Avalyn Pharma Inc.
Sign in to watch- Ticker
- AVLN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452463191
- Phone
- (206) 707-0340
- Business address
- 105 W FIRST ST., BOSTON, MA, 02127
- Former names
- Genoa Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,701,004
- in 1 filing
Net −$6,701,004. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | FMR LLC 10% owner | Sale | −5,565 | $29.56 | $165K | 2,103,970 |
| 2026-11-10 | FMR LLC 10% owner | Sale | −47,889 | $30.28 | $1.5M | 2,056,081 |
| 2026-11-09 | FMR LLC 10% owner | Sale | −173,661 | $29.06 | $5.0M | 2,110,874 |
| 2026-11-09 | FMR LLC 10% owner | Sale | −1,339 | $29.75 | $40K | 2,109,535 |
| 2026-09-15 | Meyer Robert J. Director | Grant or award · Stock Option (Right to Buy) | +31,182 | 31,182 | ||
| 2026-05-01 | Novo Holdings A/S 10% owner | Conversion | +3,327,734 | 3,327,734 | ||
| 2026-05-01 | Novo Holdings A/S 10% owner | Purchase | +555,555 | $18.00 | $10.0M | 3,883,289 |
| 2026-05-01 | Novo Holdings A/S 10% owner | Conversion · Series A Preferred Stock | −18,000,000 | 0 | ||
| 2026-05-01 | Novo Holdings A/S 10% owner | Conversion · Series B Preferred Stock | −1,986,369 | 0 | ||
| 2026-05-01 | Novo Holdings A/S 10% owner | Conversion · Series C-1 Preferred Stock | −25,899,284 | 0 | ||
| 2026-05-01 | Novo Holdings A/S 10% owner | Conversion · Series C-2 Preferred Stock | −5,587,603 | 0 | ||
| 2026-05-01 | Novo Holdings A/S 10% owner | Conversion · Series D Preferred Stock | −12,558,081 | 0 | ||
| 2026-05-01 | FMR LLC 10% owner | Conversion | +727,585 | 727,585 | ||
| 2026-05-01 | FMR LLC 10% owner | Conversion | +80,291 | 807,876 | ||
| 2026-05-01 | FMR LLC 10% owner | Conversion | +872,868 | 1,680,744 | ||
| 2026-05-01 | FMR LLC 10% owner | Conversion | +225,843 | 1,906,587 | ||
| 2026-05-01 | FMR LLC 10% owner | Conversion | +377,948 | 2,284,535 | ||
| 2026-05-01 | FMR LLC 10% owner | Conversion · Series A Preferred Stock | −727,585 | 0 | ||
| 2026-05-01 | FMR LLC 10% owner | Conversion · Series B Preferred Stock | −80,291 | 0 | ||
| 2026-05-01 | FMR LLC 10% owner | Conversion · Series C-1 Preferred Stock | −872,868 | 0 |
Page 1 of 3 · 49 trades